Home
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Community canteens fill an important gap in lives of the elderly
‘Mountains of gold and silver’ offer a relaxing getaway
Sunday
- Subscribe
Related News
Scientists need more volunteers for vaccine
Source: Xinhua |
March 22, 2009, Sunday
|
Print Edition
Print Edition
CHINESE scientists said yesterday they need to enroll more volunteers for a human test of the AIDS vaccine, as the research has moved into the second phase.
An inauguration ceremony of the second-phase research was launched yesterday in Nanning, capital of Guangxi Zhuang Autonomous Region, where the first group of 49 volunteers received the AIDS vaccine in May 2005.
"The recipients of the vaccine do not show any signs of adverse effects. Immune tests for the vaccine have also proved favorable results," said Professor Kong Wei, one of the team leaders of the program, at the event.
He said the first group of volunteers were aged between 18 and 50 when they received the vaccine. More than half of them were students from the Guangxi University of Medical Science, and others were government employees.
Dong Baiqing, head of the Guangxi Center of Disease Control and Prevention, which takes charge of the research, said researchers planned to enroll another 30 volunteers for the second-phase vaccine trial.
According to scientists, AIDS vaccine must undergo three phases of clinical trials before going into production. The first phase is focused on safety, the second phase on assessing both safety and the immunity rate of the vaccine, and the third on assessing the protection it offers for high-risk groups.
China's AIDS vaccine research started in 1996. The Ministry of Science and Technology announced the country's first phase AIDS vaccine passed clinical test in August 2006.
Figures from the Ministry of Health showed that by the end of 2008 China had reported 276,630 AIDS cases with 38,100 deaths.
An inauguration ceremony of the second-phase research was launched yesterday in Nanning, capital of Guangxi Zhuang Autonomous Region, where the first group of 49 volunteers received the AIDS vaccine in May 2005.
"The recipients of the vaccine do not show any signs of adverse effects. Immune tests for the vaccine have also proved favorable results," said Professor Kong Wei, one of the team leaders of the program, at the event.
He said the first group of volunteers were aged between 18 and 50 when they received the vaccine. More than half of them were students from the Guangxi University of Medical Science, and others were government employees.
Dong Baiqing, head of the Guangxi Center of Disease Control and Prevention, which takes charge of the research, said researchers planned to enroll another 30 volunteers for the second-phase vaccine trial.
According to scientists, AIDS vaccine must undergo three phases of clinical trials before going into production. The first phase is focused on safety, the second phase on assessing both safety and the immunity rate of the vaccine, and the third on assessing the protection it offers for high-risk groups.
China's AIDS vaccine research started in 1996. The Ministry of Science and Technology announced the country's first phase AIDS vaccine passed clinical test in August 2006.
Figures from the Ministry of Health showed that by the end of 2008 China had reported 276,630 AIDS cases with 38,100 deaths.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
